Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome - Wikidata - wikimedia - TriplyDB

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

http://www.wikidata.org/entity/Q36486798

about

Lynch syndrome from a surgeon perspective: retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years old Era of universal testing of microsatellite instability in colorectal cancer Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression Solid tumor second primary neoplasms: who is at risk, what can we do?Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment Early detection of metachronous bile duct cancer in Lynch syndrome: report of a case.Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome)The role of genome sequencing in personalized breast cancer prevention.Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.Prostate cancer incidence in males with Lynch syndrome Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.Microsatellite instability use in mismatch repair gene sequence variant classification Screening for familial and hereditary prostate cancer.Determining the familial risk distribution of colorectal cancer: a data mining approach.Frequent mismatch-repair defects link prostate cancer to Lynch syndrome Lynch syndrome and cervical cancer Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.Childhood cancers in families with and without Lynch syndrome.CUA guidelines on the management of non-muscle invasive bladder cancer.Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome Elevated risk of prostate cancer among men with Lynch syndrome.Risk of breast cancer in Lynch syndrome: a systematic review.Triple synchronous primary malignancies of the colon, endometrium and kidney in a patient with Lynch syndrome treated via minimally invasive techniques Patient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference.Modeling of successive cancer risks in Lynch syndrome families in the presence of competing risks using copulas.Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer.History, genetics, and strategies for cancer prevention in Lynch syndrome.Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors.Criteria and prediction models for mismatch repair gene mutations: a review.The dual nature of mismatch repair as antimutator and mutator: for better or for worse.Second primary cancers following colorectal cancer.Accelerated Premalignant Polyposis and Second Colon Cancers: Incriminating Immunosuppression, Radiotherapy, and Systemic Chemotherapy Agents.

P2860

Q21256711-1A4EA088-DEBB-4070-AE8A-64FF7180EBB2 Q24596823-F4F4423E-4C7D-4F78-B147-207DC4E354B1 Q26852716-02045D52-7E99-4D9F-A0E4-300A435EC4B7 Q27026266-AD00DA7E-5F35-4CA4-8BEB-341921DB3A24 Q28652056-34C92662-EF3C-4109-92C8-E2F53FF11DEF Q33796155-2EF873AD-3CBC-426E-81DB-6401E6D957BE Q34174590-2F9330BC-7E37-4459-B216-5943904F91C2 Q34266707-71271B75-8D7A-4411-B1CD-BF7F708C26E9 Q34351784-A83110CF-9271-4B92-BD17-7959E5366432 Q34458456-91539212-21D2-4524-B2AD-A0D56A269588 Q34478988-A0965D82-9808-45DB-A394-C9F341E0153F Q34901622-C4FB66EB-2473-4ECF-B21F-9AEA13AB8C76 Q34961153-95C84D72-8C8D-481D-B03B-A7B5C397F7D1 Q35063442-8A0EAF98-3912-4F95-A370-BC75637E11E9 Q35085756-D91F4AEF-E417-49A0-AA83-C05D5D1834B8 Q35118758-C01C1CBD-D13B-4E0F-96F0-DC7C7DA20F83 Q35799369-C77C7A2C-A535-40A3-9195-A7BE7EEDA068 Q35808472-1E838334-0418-4C33-9D6E-45DA46977E8E Q35861576-C7146674-219D-4C88-85B0-6E35D15BF043 Q35872667-37A2EA35-38B5-463E-B15D-C402D1CC2B5D Q35969934-72664BF5-48A3-40D7-BB9D-E7551FE54C35 Q36068742-B0E8A9BF-2DEC-4C42-BEB8-77F0758F2D6E Q36101775-8206FBD8-CB0B-41BE-911E-F27D4F7E4617 Q36244800-531453E8-D66A-4920-94CB-182A2FC94676 Q36326208-E0E8D030-6105-45D4-9539-D6482E822C4B Q36397847-1C523D7D-BA56-457C-98F0-429C62787262 Q36581642-A41F64C2-C360-4851-998E-DB986FA75E8C Q36621452-516C91B2-703D-457A-98DD-D591B44BA3BB Q36810712-9C1131D5-0E2A-4C69-A837-6A72403E19B3 Q36903207-FFFAD84C-6E17-47D5-BFC4-BCD986E11EE3 Q36990271-B5204A51-DC00-428D-8EF9-E730ED0F148E Q37579711-34B3359E-C443-4641-B1A6-2C612940D058 Q37656809-624626FA-9769-42C7-BDDB-987AE1EBA956 Q37686215-19DFE58C-D1B5-462B-9E0E-C7781334CE1B Q37716875-6379D3FB-8DEE-41DD-BB61-3D1262E03ED2 Q38093037-409A5545-4468-4829-BD73-ED08AB73DF47 Q38129858-F85B1887-E02A-4B79-B290-919669832F8B Q38246275-861AB179-2E4C-4F16-A3A3-0BE96CE03F2A Q38267732-5F91EF48-1EF0-40D5-BA62-BE1D7892B69B Q38766229-0BD6CBC2-FFCC-40DC-B8FB-940B68AB53BF

P2860

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

http://www.wikidata.org/entity/Q36486798

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

@ast

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

@en

type

label

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

@ast

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

@en

prefLabel

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

@ast

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

@en

P1433

Q36486798-733D1CC4-F8B6-4789-B287-03A3739736E6

P1476

Q36486798-CCC12513-A230-4065-B4F1-9202836F39A3

P2093

Q36486798-0A80C054-0EFA-47B2-BC72-EB99EA9071CE

Q36486798-0DBCD652-37CF-4F5D-9BD2-1EBEC957DB8B

Q36486798-1B064268-0AB0-48F2-92B6-9E4D40C65630

Q36486798-484ADE0E-68D6-4D63-827B-7C4F2265FFEC

Q36486798-768676C3-2C6A-4826-8E82-C6468CFA6DF5

Q36486798-87F71C1B-B537-4E6B-B1AE-0B1782CED236

Q36486798-8CB3E559-4145-42CB-B644-9EC007E4C336

Q36486798-8F4283AA-10F2-4208-80F3-0DE00B679B12

Q36486798-AC4EE603-B71D-4A6F-9B89-043A17B982CE

Q36486798-ADD45557-D99E-40A9-999F-DC4BEABA0E28

P2860

Q36486798-0470D104-B103-4E90-BD9B-2E7C67AD0750

Q36486798-1402B515-42D5-4A26-9508-598CD67C6811

Q36486798-161E3C4E-410D-4034-A88D-AF531EA6B7FA

Q36486798-17DEE200-22AB-4D3D-A424-75D05FF631AD

Q36486798-1CE2D9A9-FEF7-46F4-A75D-6390ED436D02

Q36486798-21B4D101-85C1-4DE8-98D5-6CB553A5E576

Q36486798-2C7B893C-1DD1-44D0-A0CE-8A7BC4628554

Q36486798-3028C565-7877-4266-9192-EF9D0C8DA9DC

Q36486798-304A62AE-FFC3-47FF-B78E-2BFC313B07C0

Q36486798-36BF94F2-FDBE-4BBC-A510-48B8299DDED0

P304

Q36486798-40B9E2FD-E579-43C8-A2EB-1AB1BB1006D1

P31

Q36486798-171D220A-1FE9-40D1-998C-D904C97BB489

P356

Q36486798-1518113B-0C07-4835-A54D-01465D3701DC

P407

Q36486798-0493FAB2-8998-47C4-B87A-14AAC71478D3

P433

Q36486798-F9BC386F-9450-4ED8-A059-4DD764D1259D

P478

Q36486798-165E2B5F-B28C-4B37-906A-9922C651F5D4

P50

Q36486798-1564DD69-C68D-4D41-9809-C32E87DCFD00

Q36486798-2A88F207-66CA-4649-AE84-B4DBCA88AF18

Q36486798-36199D28-F841-4F67-8F71-3FEC5340D430

Q36486798-4E510C8C-BDAB-476B-AB48-7B9BBE983537

Q36486798-5691C7CC-4E25-4409-B6ED-D52F19C43B48

Q36486798-6FFF6A8D-07C8-4172-8023-F17F7D309C85

Q36486798-8B144C3A-88A7-4B37-BA6D-F6B98F02692E

Q36486798-91BCD260-AB94-4A70-9102-3800D2825BC5

Q36486798-9EDD96BD-B6FF-4AEF-A3D3-A45662819791

Q36486798-B41E8005-6810-48E8-80FF-A8308D1D7B5D

P577

Q36486798-C39F7F01-0E30-4494-9FC2-8112E9C721FB

P5875

Q36486798-BF6B1523-B353-4BEE-8CDB-124E8ACED0DA

P698

Q36486798-743317A4-FAD4-46AF-BCE2-91C856775BAC

P921

Q36486798-C4289874-FCEE-48C3-B02C-D4AE40D7C36F

P932

Q36486798-4971EAEE-31A3-427C-8B43-D3EE0542087F

P356

P1433

Journal of the National Cancer Institute

P1476

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome

@en

P2093

A Joan Levine

http://www.w3.org/2001/XMLSchema#string

Barbara Leggett

http://www.w3.org/2001/XMLSchema#string

Finlay A Macrae

http://www.w3.org/2001/XMLSchema#string

Graeme P Young

http://www.w3.org/2001/XMLSchema#string

Jack Goldblatt

http://www.w3.org/2001/XMLSchema#string

Joanne P Young

http://www.w3.org/2001/XMLSchema#string

Julie Arnold

http://www.w3.org/2001/XMLSchema#string

Katherine M Tucker

http://www.w3.org/2001/XMLSchema#string

Lara Lipton

http://www.w3.org/2001/XMLSchema#string

Mark Clendenning

http://www.w3.org/2001/XMLSchema#string

P2860

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

Risks of Lynch syndrome cancers for MSH6 mutation carriers.

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery

Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non-polyposis colorectal cancer.

Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry

The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study.

Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.

Risk of pancreatic cancer in families with Lynch syndrome.

P304

1363-1372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJS351

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Steven Gallinger

Loic Le Marchand

Graham G. Giles

Elizabeth Williamson

Daniel D Buchanan

Christophe Rosty

P577

2012-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230763522

http://www.w3.org/2001/XMLSchema#string

P698

22933731

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3529597

http://www.w3.org/2001/XMLSchema#string